report cover

Global Alirocumab Market Research Report 2022

  • 04 November 2022
  • Life Sciences
  • 121 Pages
  • Report code : 24WT-7474335

Alirocumab Market

1 Alirocumab Market Overview
1.1 Product Overview and Scope of Alirocumab
1.2 Alirocumab Segment by Type
1.2.1 Global Alirocumab Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Patent
1.2.3 Generic
1.3 Alirocumab Segment by Application
1.3.1 Global Alirocumab Sales Comparison by Application: (2022-2028)
1.3.2 Biochemical Reagents
1.3.3 Pharmaceutical Intermediates
1.4 Global Alirocumab Market Size Estimates and Forecasts
1.4.1 Global Alirocumab Revenue 2017-2028
1.4.2 Global Alirocumab Sales 2017-2028
1.4.3 Alirocumab Market Size by Region: 2017 Versus 2021 Versus 2028
2 Alirocumab Market Competition by Manufacturers
2.1 Global Alirocumab Sales Market Share by Manufacturers (2017-2022)
2.2 Global Alirocumab Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Alirocumab Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Alirocumab Manufacturing Sites, Area Served, Product Type
2.5 Alirocumab Market Competitive Situation and Trends
2.5.1 Alirocumab Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Alirocumab Players Market Share by Revenue
2.5.3 Global Alirocumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Alirocumab Retrospective Market Scenario by Region
3.1 Global Alirocumab Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Alirocumab Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Alirocumab Market Facts & Figures by Country
3.3.1 North America Alirocumab Sales by Country
3.3.2 North America Alirocumab Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Alirocumab Market Facts & Figures by Country
3.4.1 Europe Alirocumab Sales by Country
3.4.2 Europe Alirocumab Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Alirocumab Market Facts & Figures by Region
3.5.1 Asia Pacific Alirocumab Sales by Region
3.5.2 Asia Pacific Alirocumab Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Alirocumab Market Facts & Figures by Country
3.6.1 Latin America Alirocumab Sales by Country
3.6.2 Latin America Alirocumab Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Alirocumab Market Facts & Figures by Country
3.7.1 Middle East and Africa Alirocumab Sales by Country
3.7.2 Middle East and Africa Alirocumab Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Alirocumab Historic Market Analysis by Type
4.1 Global Alirocumab Sales Market Share by Type (2017-2022)
4.2 Global Alirocumab Revenue Market Share by Type (2017-2022)
4.3 Global Alirocumab Price by Type (2017-2022)
5 Global Alirocumab Historic Market Analysis by Application
5.1 Global Alirocumab Sales Market Share by Application (2017-2022)
5.2 Global Alirocumab Revenue Market Share by Application (2017-2022)
5.3 Global Alirocumab Price by Application (2017-2022)
6 Key Companies Profiled
6.1 AK Scientific
6.1.1 AK Scientific Corporation Information
6.1.2 AK Scientific Description and Business Overview
6.1.3 AK Scientific Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.1.4 AK Scientific Alirocumab Product Portfolio
6.1.5 AK Scientific Recent Developments/Updates
6.2 Carbosynth
6.2.1 Carbosynth Corporation Information
6.2.2 Carbosynth Description and Business Overview
6.2.3 Carbosynth Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Carbosynth Alirocumab Product Portfolio
6.2.5 Carbosynth Recent Developments/Updates
6.3 TargetMol Chemicals
6.3.1 TargetMol Chemicals Corporation Information
6.3.2 TargetMol Chemicals Description and Business Overview
6.3.3 TargetMol Chemicals Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.3.4 TargetMol Chemicals Alirocumab Product Portfolio
6.3.5 TargetMol Chemicals Recent Developments/Updates
6.4 Beijing Aomi Jiade Pharmaceutical Technology
6.4.1 Beijing Aomi Jiade Pharmaceutical Technology Corporation Information
6.4.2 Beijing Aomi Jiade Pharmaceutical Technology Description and Business Overview
6.4.3 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Product Portfolio
6.4.5 Beijing Aomi Jiade Pharmaceutical Technology Recent Developments/Updates
6.5 Hefei Hirisun Pharmatech
6.5.1 Hefei Hirisun Pharmatech Corporation Information
6.5.2 Hefei Hirisun Pharmatech Description and Business Overview
6.5.3 Hefei Hirisun Pharmatech Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Hefei Hirisun Pharmatech Alirocumab Product Portfolio
6.5.5 Hefei Hirisun Pharmatech Recent Developments/Updates
6.6 Hubei Widely Chemical Technology
6.6.1 Hubei Widely Chemical Technology Corporation Information
6.6.2 Hubei Widely Chemical Technology Description and Business Overview
6.6.3 Hubei Widely Chemical Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Hubei Widely Chemical Technology Alirocumab Product Portfolio
6.6.5 Hubei Widely Chemical Technology Recent Developments/Updates
6.7 Hubei Xingcheng Biotechnology
6.6.1 Hubei Xingcheng Biotechnology Corporation Information
6.6.2 Hubei Xingcheng Biotechnology Description and Business Overview
6.6.3 Hubei Xingcheng Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Hubei Xingcheng Biotechnology Alirocumab Product Portfolio
6.7.5 Hubei Xingcheng Biotechnology Recent Developments/Updates
6.8 Hubei Zhongshan Medical Technology
6.8.1 Hubei Zhongshan Medical Technology Corporation Information
6.8.2 Hubei Zhongshan Medical Technology Description and Business Overview
6.8.3 Hubei Zhongshan Medical Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Hubei Zhongshan Medical Technology Alirocumab Product Portfolio
6.8.5 Hubei Zhongshan Medical Technology Recent Developments/Updates
6.9 Jiangxi Ruiweier Biotechnology
6.9.1 Jiangxi Ruiweier Biotechnology Corporation Information
6.9.2 Jiangxi Ruiweier Biotechnology Description and Business Overview
6.9.3 Jiangxi Ruiweier Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Jiangxi Ruiweier Biotechnology Alirocumab Product Portfolio
6.9.5 Jiangxi Ruiweier Biotechnology Recent Developments/Updates
6.10 Kailide Biomedical Technology
6.10.1 Kailide Biomedical Technology Corporation Information
6.10.2 Kailide Biomedical Technology Description and Business Overview
6.10.3 Kailide Biomedical Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Kailide Biomedical Technology Alirocumab Product Portfolio
6.10.5 Kailide Biomedical Technology Recent Developments/Updates
6.11 Nantong Feiyu Biological Technology
6.11.1 Nantong Feiyu Biological Technology Corporation Information
6.11.2 Nantong Feiyu Biological Technology Alirocumab Description and Business Overview
6.11.3 Nantong Feiyu Biological Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Nantong Feiyu Biological Technology Alirocumab Product Portfolio
6.11.5 Nantong Feiyu Biological Technology Recent Developments/Updates
6.12 Nantong Hi-Future Biotechnology
6.12.1 Nantong Hi-Future Biotechnology Corporation Information
6.12.2 Nantong Hi-Future Biotechnology Alirocumab Description and Business Overview
6.12.3 Nantong Hi-Future Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Nantong Hi-Future Biotechnology Alirocumab Product Portfolio
6.12.5 Nantong Hi-Future Biotechnology Recent Developments/Updates
6.13 Shanghai Baishikai Chemical Technology
6.13.1 Shanghai Baishikai Chemical Technology Corporation Information
6.13.2 Shanghai Baishikai Chemical Technology Alirocumab Description and Business Overview
6.13.3 Shanghai Baishikai Chemical Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Shanghai Baishikai Chemical Technology Alirocumab Product Portfolio
6.13.5 Shanghai Baishikai Chemical Technology Recent Developments/Updates
6.14 Shanghai Biochempartner
6.14.1 Shanghai Biochempartner Corporation Information
6.14.2 Shanghai Biochempartner Alirocumab Description and Business Overview
6.14.3 Shanghai Biochempartner Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Shanghai Biochempartner Alirocumab Product Portfolio
6.14.5 Shanghai Biochempartner Recent Developments/Updates
6.15 Shanghai Loulan Biotechnology
6.15.1 Shanghai Loulan Biotechnology Corporation Information
6.15.2 Shanghai Loulan Biotechnology Alirocumab Description and Business Overview
6.15.3 Shanghai Loulan Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Shanghai Loulan Biotechnology Alirocumab Product Portfolio
6.15.5 Shanghai Loulan Biotechnology Recent Developments/Updates
6.16 Shanghai Macklin Biochemical
6.16.1 Shanghai Macklin Biochemical Corporation Information
6.16.2 Shanghai Macklin Biochemical Alirocumab Description and Business Overview
6.16.3 Shanghai Macklin Biochemical Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Shanghai Macklin Biochemical Alirocumab Product Portfolio
6.16.5 Shanghai Macklin Biochemical Recent Developments/Updates
6.17 Shanghai Minkai Biotechnology
6.17.1 Shanghai Minkai Biotechnology Corporation Information
6.17.2 Shanghai Minkai Biotechnology Alirocumab Description and Business Overview
6.17.3 Shanghai Minkai Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Shanghai Minkai Biotechnology Alirocumab Product Portfolio
6.17.5 Shanghai Minkai Biotechnology Recent Developments/Updates
6.18 Shanghai Ruihui Chemical Technology
6.18.1 Shanghai Ruihui Chemical Technology Corporation Information
6.18.2 Shanghai Ruihui Chemical Technology Alirocumab Description and Business Overview
6.18.3 Shanghai Ruihui Chemical Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Shanghai Ruihui Chemical Technology Alirocumab Product Portfolio
6.18.5 Shanghai Ruihui Chemical Technology Recent Developments/Updates
6.19 Shanghai Saimai Biotechnology
6.19.1 Shanghai Saimai Biotechnology Corporation Information
6.19.2 Shanghai Saimai Biotechnology Alirocumab Description and Business Overview
6.19.3 Shanghai Saimai Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Shanghai Saimai Biotechnology Alirocumab Product Portfolio
6.19.5 Shanghai Saimai Biotechnology Recent Developments/Updates
6.20 Shanghai Yifei Biotechnology
6.20.1 Shanghai Yifei Biotechnology Corporation Information
6.20.2 Shanghai Yifei Biotechnology Alirocumab Description and Business Overview
6.20.3 Shanghai Yifei Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Shanghai Yifei Biotechnology Alirocumab Product Portfolio
6.20.5 Shanghai Yifei Biotechnology Recent Developments/Updates
6.21 Sichuan Weiqi Biotechnology
6.21.1 Sichuan Weiqi Biotechnology Corporation Information
6.21.2 Sichuan Weiqi Biotechnology Alirocumab Description and Business Overview
6.21.3 Sichuan Weiqi Biotechnology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.21.4 Sichuan Weiqi Biotechnology Alirocumab Product Portfolio
6.21.5 Sichuan Weiqi Biotechnology Recent Developments/Updates
6.22 Taizhou KEDE Chemical
6.22.1 Taizhou KEDE Chemical Corporation Information
6.22.2 Taizhou KEDE Chemical Alirocumab Description and Business Overview
6.22.3 Taizhou KEDE Chemical Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Taizhou KEDE Chemical Alirocumab Product Portfolio
6.22.5 Taizhou KEDE Chemical Recent Developments/Updates
6.23 Taizhou Kerui Bio-Technology
6.23.1 Taizhou Kerui Bio-Technology Corporation Information
6.23.2 Taizhou Kerui Bio-Technology Alirocumab Description and Business Overview
6.23.3 Taizhou Kerui Bio-Technology Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Taizhou Kerui Bio-Technology Alirocumab Product Portfolio
6.23.5 Taizhou Kerui Bio-Technology Recent Developments/Updates
6.24 Tianmen Hengchang Chemical
6.24.1 Tianmen Hengchang Chemical Corporation Information
6.24.2 Tianmen Hengchang Chemical Alirocumab Description and Business Overview
6.24.3 Tianmen Hengchang Chemical Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Tianmen Hengchang Chemical Alirocumab Product Portfolio
6.24.5 Tianmen Hengchang Chemical Recent Developments/Updates
6.25 WeiShi Reagent
6.25.1 WeiShi Reagent Corporation Information
6.25.2 WeiShi Reagent Alirocumab Description and Business Overview
6.25.3 WeiShi Reagent Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.25.4 WeiShi Reagent Alirocumab Product Portfolio
6.25.5 WeiShi Reagent Recent Developments/Updates
6.26 Wuhan Dingxintong Pharmaceutical
6.26.1 Wuhan Dingxintong Pharmaceutical Corporation Information
6.26.2 Wuhan Dingxintong Pharmaceutical Alirocumab Description and Business Overview
6.26.3 Wuhan Dingxintong Pharmaceutical Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.26.4 Wuhan Dingxintong Pharmaceutical Alirocumab Product Portfolio
6.26.5 Wuhan Dingxintong Pharmaceutical Recent Developments/Updates
6.27 Wuhan Fortuna Chemical
6.27.1 Wuhan Fortuna Chemical Corporation Information
6.27.2 Wuhan Fortuna Chemical Alirocumab Description and Business Overview
6.27.3 Wuhan Fortuna Chemical Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.27.4 Wuhan Fortuna Chemical Alirocumab Product Portfolio
6.27.5 Wuhan Fortuna Chemical Recent Developments/Updates
6.28 Wuhan Sunrise Technology Development
6.28.1 Wuhan Sunrise Technology Development Corporation Information
6.28.2 Wuhan Sunrise Technology Development Alirocumab Description and Business Overview
6.28.3 Wuhan Sunrise Technology Development Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.28.4 Wuhan Sunrise Technology Development Alirocumab Product Portfolio
6.28.5 Wuhan Sunrise Technology Development Recent Developments/Updates
6.29 Wuhan Weisman Bioengineering
6.29.1 Wuhan Weisman Bioengineering Corporation Information
6.29.2 Wuhan Weisman Bioengineering Alirocumab Description and Business Overview
6.29.3 Wuhan Weisman Bioengineering Alirocumab Sales, Revenue and Gross Margin (2017-2022)
6.29.4 Wuhan Weisman Bioengineering Alirocumab Product Portfolio
6.29.5 Wuhan Weisman Bioengineering Recent Developments/Updates
7 Alirocumab Manufacturing Cost Analysis
7.1 Alirocumab Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Alirocumab
7.4 Alirocumab Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Alirocumab Distributors List
8.3 Alirocumab Customers
9 Alirocumab Market Dynamics
9.1 Alirocumab Industry Trends
9.2 Alirocumab Market Drivers
9.3 Alirocumab Market Challenges
9.4 Alirocumab Market Restraints
10 Global Market Forecast
10.1 Alirocumab Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Alirocumab by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Alirocumab by Type (2023-2028)
10.2 Alirocumab Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Alirocumab by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Alirocumab by Application (2023-2028)
10.3 Alirocumab Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Alirocumab by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Alirocumab by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
Ask Our Expert

Leave This Empty:

*Required Information
List of Tables
Table 1. Global Alirocumab Sales Growth Rate Comparison by Type (2022-2028) & (Kg) & (US$ Million)
Table 2. Global Alirocumab Sales Growth Rate Comparison by Application (2022-2028) & (Kg) & (US$ Million)
Table 3. Global Alirocumab Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Alirocumab Market Competitive Situation by Manufacturers in 2021
Table 5. Global Alirocumab Sales (Kg) of Key Manufacturers (2017-2022)
Table 6. Global Alirocumab Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Alirocumab Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Alirocumab Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Alirocumab Average Price (US$/Kg) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Alirocumab Manufacturing Sites and Area Served
Table 11. Manufacturers Alirocumab Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Alirocumab by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Alirocumab as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Alirocumab Sales by Region (2017-2022) & (Kg)
Table 16. Global Alirocumab Sales Market Share by Region (2017-2022)
Table 17. Global Alirocumab Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Alirocumab Revenue Market Share by Region (2017-2022)
Table 19. North America Alirocumab Sales by Country (2017-2022) & (Kg)
Table 20. North America Alirocumab Sales Market Share by Country (2017-2022)
Table 21. North America Alirocumab Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Alirocumab Revenue Market Share by Country (2017-2022)
Table 23. Europe Alirocumab Sales by Country (2017-2022) & (Kg)
Table 24. Europe Alirocumab Sales Market Share by Country (2017-2022)
Table 25. Europe Alirocumab Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Alirocumab Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Alirocumab Sales by Region (2017-2022) & (Kg)
Table 28. Asia Pacific Alirocumab Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Alirocumab Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Alirocumab Revenue Market Share by Region (2017-2022)
Table 31. Latin America Alirocumab Sales by Country (2017-2022) & (Kg)
Table 32. Latin America Alirocumab Sales Market Share by Country (2017-2022)
Table 33. Latin America Alirocumab Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Alirocumab Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Alirocumab Sales by Country (2017-2022) & (Kg)
Table 36. Middle East and Africa Alirocumab Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Alirocumab Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Alirocumab Revenue Market Share by Country (2017-2022)
Table 39. Global Alirocumab Sales by Type (2017-2022) & (Kg)
Table 40. Global Alirocumab Sales Market Share by Type (2017-2022)
Table 41. Global Alirocumab Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Alirocumab Revenue Share by Type (2017-2022)
Table 43. Global Alirocumab Price by Type (2017-2022) & (US$/Kg)
Table 44. Global Alirocumab Sales (Kg) by Application (2017-2022)
Table 45. Global Alirocumab Sales Market Share by Application (2017-2022)
Table 46. Global Alirocumab Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Alirocumab Revenue Share by Application (2017-2022)
Table 48. Global Alirocumab Price by Application (2017-2022) & (US$/Kg)
Table 49. AK Scientific Corporation Information
Table 50. AK Scientific Description and Business Overview
Table 51. AK Scientific Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 52. AK Scientific Alirocumab Product
Table 53. AK Scientific Recent Developments/Updates
Table 54. Carbosynth Corporation Information
Table 55. Carbosynth Description and Business Overview
Table 56. Carbosynth Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 57. Carbosynth Alirocumab Product
Table 58. Carbosynth Recent Developments/Updates
Table 59. TargetMol Chemicals Corporation Information
Table 60. TargetMol Chemicals Description and Business Overview
Table 61. TargetMol Chemicals Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 62. TargetMol Chemicals Alirocumab Product
Table 63. TargetMol Chemicals Recent Developments/Updates
Table 64. Beijing Aomi Jiade Pharmaceutical Technology Corporation Information
Table 65. Beijing Aomi Jiade Pharmaceutical Technology Description and Business Overview
Table 66. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 67. Beijing Aomi Jiade Pharmaceutical Technology Alirocumab Product
Table 68. Beijing Aomi Jiade Pharmaceutical Technology Recent Developments/Updates
Table 69. Hefei Hirisun Pharmatech Corporation Information
Table 70. Hefei Hirisun Pharmatech Description and Business Overview
Table 71. Hefei Hirisun Pharmatech Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 72. Hefei Hirisun Pharmatech Alirocumab Product
Table 73. Hefei Hirisun Pharmatech Recent Developments/Updates
Table 74. Hubei Widely Chemical Technology Corporation Information
Table 75. Hubei Widely Chemical Technology Description and Business Overview
Table 76. Hubei Widely Chemical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 77. Hubei Widely Chemical Technology Alirocumab Product
Table 78. Hubei Widely Chemical Technology Recent Developments/Updates
Table 79. Hubei Xingcheng Biotechnology Corporation Information
Table 80. Hubei Xingcheng Biotechnology Description and Business Overview
Table 81. Hubei Xingcheng Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 82. Hubei Xingcheng Biotechnology Alirocumab Product
Table 83. Hubei Xingcheng Biotechnology Recent Developments/Updates
Table 84. Hubei Zhongshan Medical Technology Corporation Information
Table 85. Hubei Zhongshan Medical Technology Description and Business Overview
Table 86. Hubei Zhongshan Medical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 87. Hubei Zhongshan Medical Technology Alirocumab Product
Table 88. Hubei Zhongshan Medical Technology Recent Developments/Updates
Table 89. Jiangxi Ruiweier Biotechnology Corporation Information
Table 90. Jiangxi Ruiweier Biotechnology Description and Business Overview
Table 91. Jiangxi Ruiweier Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 92. Jiangxi Ruiweier Biotechnology Alirocumab Product
Table 93. Jiangxi Ruiweier Biotechnology Recent Developments/Updates
Table 94. Kailide Biomedical Technology Corporation Information
Table 95. Kailide Biomedical Technology Description and Business Overview
Table 96. Kailide Biomedical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 97. Kailide Biomedical Technology Alirocumab Product
Table 98. Kailide Biomedical Technology Recent Developments/Updates
Table 99. Nantong Feiyu Biological Technology Corporation Information
Table 100. Nantong Feiyu Biological Technology Description and Business Overview
Table 101. Nantong Feiyu Biological Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 102. Nantong Feiyu Biological Technology Alirocumab Product
Table 103. Nantong Feiyu Biological Technology Recent Developments/Updates
Table 104. Nantong Hi-Future Biotechnology Corporation Information
Table 105. Nantong Hi-Future Biotechnology Description and Business Overview
Table 106. Nantong Hi-Future Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 107. Nantong Hi-Future Biotechnology Alirocumab Product
Table 108. Nantong Hi-Future Biotechnology Recent Developments/Updates
Table 109. Shanghai Baishikai Chemical Technology Corporation Information
Table 110. Shanghai Baishikai Chemical Technology Description and Business Overview
Table 111. Shanghai Baishikai Chemical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 112. Shanghai Baishikai Chemical Technology Alirocumab Product
Table 113. Shanghai Baishikai Chemical Technology Recent Developments/Updates
Table 114. Shanghai Biochempartner Corporation Information
Table 115. Shanghai Biochempartner Description and Business Overview
Table 116. Shanghai Biochempartner Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 117. Shanghai Biochempartner Alirocumab Product
Table 118. Shanghai Biochempartner Recent Developments/Updates
Table 119. Shanghai Loulan Biotechnology Corporation Information
Table 120. Shanghai Loulan Biotechnology Description and Business Overview
Table 121. Shanghai Loulan Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 122. Shanghai Loulan Biotechnology Alirocumab Product
Table 123. Shanghai Loulan Biotechnology Recent Developments/Updates
Table 124. Shanghai Macklin Biochemical Corporation Information
Table 125. Shanghai Macklin Biochemical Description and Business Overview
Table 126. Shanghai Macklin Biochemical Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 127. Shanghai Macklin Biochemical Alirocumab Product
Table 128. Shanghai Macklin Biochemical Recent Developments/Updates
Table 129. Shanghai Minkai Biotechnology Corporation Information
Table 130. Shanghai Minkai Biotechnology Description and Business Overview
Table 131. Shanghai Minkai Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 132. Shanghai Minkai Biotechnology Alirocumab Product
Table 133. Shanghai Minkai Biotechnology Recent Developments/Updates
Table 134. Shanghai Ruihui Chemical Technology Corporation Information
Table 135. Shanghai Ruihui Chemical Technology Description and Business Overview
Table 136. Shanghai Ruihui Chemical Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 137. Shanghai Ruihui Chemical Technology Alirocumab Product
Table 138. Shanghai Ruihui Chemical Technology Recent Developments/Updates
Table 139. Shanghai Saimai Biotechnology Corporation Information
Table 140. Shanghai Saimai Biotechnology Description and Business Overview
Table 141. Shanghai Saimai Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 142. Shanghai Saimai Biotechnology Alirocumab Product
Table 143. Shanghai Saimai Biotechnology Recent Developments/Updates
Table 144. Shanghai Yifei Biotechnology Corporation Information
Table 145. Shanghai Yifei Biotechnology Description and Business Overview
Table 146. Shanghai Yifei Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 147. Shanghai Yifei Biotechnology Alirocumab Product
Table 148. Shanghai Yifei Biotechnology Recent Developments/Updates
Table 149. Sichuan Weiqi Biotechnology Corporation Information
Table 150. Sichuan Weiqi Biotechnology Description and Business Overview
Table 151. Sichuan Weiqi Biotechnology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 152. Sichuan Weiqi Biotechnology Alirocumab Product
Table 153. Sichuan Weiqi Biotechnology Recent Developments/Updates
Table 154. Taizhou KEDE Chemical Corporation Information
Table 155. Taizhou KEDE Chemical Description and Business Overview
Table 156. Taizhou KEDE Chemical Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 157. Taizhou KEDE Chemical Alirocumab Product
Table 158. Taizhou KEDE Chemical Recent Developments/Updates
Table 159. Taizhou Kerui Bio-Technology Corporation Information
Table 160. Taizhou Kerui Bio-Technology Description and Business Overview
Table 161. Taizhou Kerui Bio-Technology Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 162. Taizhou Kerui Bio-Technology Alirocumab Product
Table 163. Taizhou Kerui Bio-Technology Recent Developments/Updates
Table 164. Tianmen Hengchang Chemical Corporation Information
Table 165. Tianmen Hengchang Chemical Description and Business Overview
Table 166. Tianmen Hengchang Chemical Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 167. Tianmen Hengchang Chemical Alirocumab Product
Table 168. Tianmen Hengchang Chemical Recent Developments/Updates
Table 169. WeiShi Reagent Corporation Information
Table 170. WeiShi Reagent Description and Business Overview
Table 171. WeiShi Reagent Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 172. WeiShi Reagent Alirocumab Product
Table 173. WeiShi Reagent Recent Developments/Updates
Table 174. Wuhan Dingxintong Pharmaceutical Corporation Information
Table 175. Wuhan Dingxintong Pharmaceutical Description and Business Overview
Table 176. Wuhan Dingxintong Pharmaceutical Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 177. Wuhan Dingxintong Pharmaceutical Alirocumab Product
Table 178. Wuhan Dingxintong Pharmaceutical Recent Developments/Updates
Table 179. Wuhan Fortuna Chemical Corporation Information
Table 180. Wuhan Fortuna Chemical Description and Business Overview
Table 181. Wuhan Fortuna Chemical Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 182. Wuhan Fortuna Chemical Alirocumab Product
Table 183. Wuhan Fortuna Chemical Recent Developments/Updates
Table 184. Wuhan Sunrise Technology Development Corporation Information
Table 185. Wuhan Sunrise Technology Development Description and Business Overview
Table 186. Wuhan Sunrise Technology Development Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 187. Wuhan Sunrise Technology Development Alirocumab Product
Table 188. Wuhan Sunrise Technology Development Recent Developments/Updates
Table 189. Wuhan Weisman Bioengineering Corporation Information
Table 190. Wuhan Weisman Bioengineering Description and Business Overview
Table 191. Wuhan Weisman Bioengineering Alirocumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 192. Wuhan Weisman Bioengineering Alirocumab Product
Table 193. Wuhan Weisman Bioengineering Recent Developments/Updates
Table 194. Production Base and Market Concentration Rate of Raw Material
Table 195. Key Suppliers of Raw Materials
Table 196. Alirocumab Distributors List
Table 197. Alirocumab Customers List
Table 198. Alirocumab Market Trends
Table 199. Alirocumab Market Drivers
Table 200. Alirocumab Market Challenges
Table 201. Alirocumab Market Restraints
Table 202. Global Alirocumab Sales Forecast by Type (2023-2028) & (Kg)
Table 203. Global Alirocumab Sales Market Share Forecast by Type (2023-2028)
Table 204. Global Alirocumab Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 205. Global Alirocumab Revenue Market Share Forecast by Type (2023-2028)
Table 206. Global Alirocumab Sales Forecast by Application (2023-2028) & (Kg)
Table 207. Global Alirocumab Sales Market Share Forecast by Application (2023-2028)
Table 208. Global Alirocumab Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 209. Global Alirocumab Revenue Market Share Forecast by Application (2023-2028)
Table 210. Global Alirocumab Sales Forecast by Region (2023-2028) & (Kg)
Table 211. Global Alirocumab Sales Market Share Forecast by Region (2023-2028)
Table 212. Global Alirocumab Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 213. Global Alirocumab Revenue Market Share Forecast by Region (2023-2028)
Table 214. Research Programs/Design for This Report
Table 215. Key Data Information from Secondary Sources
Table 216. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Alirocumab
Figure 2. Global Alirocumab Market Share by Type in 2021 & 2028
Figure 3. Patent Product Picture
Figure 4. Generic Product Picture
Figure 5. Global Alirocumab Market Share by Application in 2021 & 2028
Figure 6. Biochemical Reagents
Figure 7. Pharmaceutical Intermediates
Figure 8. Global Alirocumab Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 9. Global Alirocumab Market Size (2017-2028) & (US$ Million)
Figure 10. Global Alirocumab Sales (2017-2028) & (Kg)
Figure 11. Alirocumab Sales Share by Manufacturers in 2021
Figure 12. Global Alirocumab Revenue Share by Manufacturers in 2021
Figure 13. The Global 5 and 10 Largest Alirocumab Players: Market Share by Revenue in 2021
Figure 14. Alirocumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 15. Global Alirocumab Sales Market Share by Region (2017-2022)
Figure 16. Global Alirocumab Sales Market Share by Region in 2021
Figure 17. Global Alirocumab Revenue Market Share by Region (2017-2022)
Figure 18. Global Alirocumab Revenue Market Share by Region in 2021
Figure 19. United States Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 20. Canada Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Germany Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. France Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. U.K. Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Italy Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Russia Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. China Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Japan Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. South Korea Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. India Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Australia Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. China Taiwan Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Indonesia Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Thailand Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Malaysia Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Mexico Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Brazil Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Argentina Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Turkey Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Saudi Arabia Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. UAE Alirocumab Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Sales Market Share of Alirocumab by Type (2017-2022)
Figure 42. Manufacturing Cost Structure of Alirocumab
Figure 43. Manufacturing Process Analysis of Alirocumab
Figure 44. Alirocumab Industrial Chain Analysis
Figure 45. Channels of Distribution
Figure 46. Distributors Profiles
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed

Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Alirocumab Market

Leave This Empty: